Bio-Works Technologies AB
Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chr… Read more
Bio-Works Technologies AB (BIOWKS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.236x
Based on the latest financial reports, Bio-Works Technologies AB (BIOWKS) has a cash flow conversion efficiency ratio of -0.236x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-7.09 Million) by net assets (Skr30.04 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bio-Works Technologies AB - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Bio-Works Technologies AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bio-Works Technologies AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bio-Works Technologies AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SIL Investments Limited
NSE:SILINV
|
0.024x |
|
AUX Resources Corporation
V:AUX
|
-0.314x |
|
Po Valley Energy Ltd
AU:PVE
|
0.148x |
|
Kapa Gold Inc.
V:KAPA
|
-0.030x |
|
K-One Technology Bhd
KLSE:0111
|
0.102x |
|
CryoCell International Inc
NYSE MKT:CCEL
|
-0.171x |
|
AGAT EJENDOMME NAM. DK 1
F:2TD
|
N/A |
|
Wijaya Karya Beton
JK:WTON
|
0.038x |
Annual Cash Flow Conversion Efficiency for Bio-Works Technologies AB (2015–2024)
The table below shows the annual cash flow conversion efficiency of Bio-Works Technologies AB from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr44.58 Million | Skr-43.17 Million | -0.968x | +27.73% |
| 2023-12-31 | Skr44.03 Million | Skr-58.99 Million | -1.340x | -127.40% |
| 2022-12-31 | Skr67.69 Million | Skr-39.88 Million | -0.589x | -378.17% |
| 2021-12-31 | Skr108.51 Million | Skr-13.37 Million | -0.123x | +89.36% |
| 2020-12-31 | Skr37.46 Million | Skr-43.36 Million | -1.158x | -137.44% |
| 2019-12-31 | Skr82.13 Million | Skr-40.04 Million | -0.488x | +13.37% |
| 2018-12-31 | Skr61.64 Million | Skr-34.69 Million | -0.563x | -163.23% |
| 2017-12-31 | Skr99.32 Million | Skr-21.23 Million | -0.214x | +65.04% |
| 2016-12-31 | Skr23.64 Million | Skr-14.46 Million | -0.612x | -4.42% |
| 2015-12-31 | Skr22.41 Million | Skr-13.12 Million | -0.586x | -- |